Abstract
Detection of unknown mutations is a key for success in diagnosis, treatment and therapy of many genetic diseases. Use of chemicals has been practiced for many years to probe the structural changes of DNA induced by a single base mismatch. This paper will review the current chemicals, such as carbodiimides, alkyl halides, aldehydes, oxidants, oxyamines, intercalators and groove binders, which have established the foundation for many useful applications in the areas of genetics and molecular biology.
Current Pharmacogenomics
Title: Current Chemicals Used for Probing DNA Conformational Changes and Detection of Unknown Mutations
Volume: 2 Issue: 4
Author(s): Chinh T. Bui, Kylee Rees and Richard G. H. Cotton
Affiliation:
Abstract: Detection of unknown mutations is a key for success in diagnosis, treatment and therapy of many genetic diseases. Use of chemicals has been practiced for many years to probe the structural changes of DNA induced by a single base mismatch. This paper will review the current chemicals, such as carbodiimides, alkyl halides, aldehydes, oxidants, oxyamines, intercalators and groove binders, which have established the foundation for many useful applications in the areas of genetics and molecular biology.
Export Options
About this article
Cite this article as:
Bui T. Chinh, Rees Kylee and Cotton G. H. Richard, Current Chemicals Used for Probing DNA Conformational Changes and Detection of Unknown Mutations, Current Pharmacogenomics 2004; 2 (4) . https://dx.doi.org/10.2174/1570160043377312
DOI https://dx.doi.org/10.2174/1570160043377312 |
Print ISSN 1570-1603 |
Publisher Name Bentham Science Publisher |
Online ISSN 1570-1603 |
Related Articles
-
The Role of Phospholipase D Enzyme(s) in Modulating Cell Signaling: Implications for Cancer Drug Development
Current Bioactive Compounds Anti-Tumor Activity of Non-Nucleosidic Reverse Transcriptase Inhibitors
Current Pharmaceutical Design Update on Cancer Related Issues of Mesenchymal Stem Cell-Based Therapies
Current Stem Cell Research & Therapy Multidisciplinary Approach to Rectal Cancer: Are we Ready for Selective Treatment Strategies?
Anti-Cancer Agents in Medicinal Chemistry Generating ‘Omic Knowledge’: The Role of Informatics in High Content Screening
Combinatorial Chemistry & High Throughput Screening Persistent GP130/STAT3 Signaling Contributes to the Resistance of Doxorubicin, Cisplatin, and MEK Inhibitor in Human Rhabdomyosarcoma Cells
Current Cancer Drug Targets Reversion of Multidrug Resistance in Tumor By Biocompatible Nanomaterials
Mini-Reviews in Medicinal Chemistry Activation of Intrinsic Apoptosis and G1 Cell Cycle Arrest by a Triazole Precursor, N-(4-chlorophenyl)-2-(4-(3,4,5-trimethoxybenzyloxy)benzoyl)-hydrazinecarbothioamide in Breast Cancer Cell Line
Anti-Cancer Agents in Medicinal Chemistry A Clinician’s Guide to Monoamine Oxidase Inhibitors
Current Psychiatry Reviews ING Proteins as Potential Anticancer Drug Targets
Current Drug Targets P-Glycoprotein - Implications of Metabolism of Neoplastic Cells and Cancer Therapy
Current Cancer Drug Targets Pore-forming Peptides: A New Treatment Option for Cancer
Current Medicinal Chemistry Therapeutic microRNA Delivery Strategies with Special Emphasis on Cancer Therapy and Tumorigenesis: Current Trends and Future Challenges
Current Drug Metabolism The CLCA Gene Family: Putative Therapeutic Target for Respiratory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Brain Targeted Drug Delivery: Factors, Approaches and Patents
Recent Patents on Nanomedicine Combination of Anti-EGFR Drugs and Other Molecular Targeted Agents as Anti-Cancer Strategy
Current Cancer Therapy Reviews Iron Chelators in Cancer Chemotherapy
Current Topics in Medicinal Chemistry Accelerated Cytotoxicity Mechanism Screening Using Drug Metabolising Enzyme Modulators
Current Drug Metabolism PEDF & Stem Cells: Niche vs. Nurture
Current Drug Delivery The Need for Calcium Channels in Cell Proliferation
Recent Patents on Anti-Cancer Drug Discovery